Toronto, Ontario--(Newsfile Corp. - September 18, 2017) - DNI Metals Inc. (CSE: DNI) (OTC Pink: DMNKF) ("DNI", "the Company") is pleased to announce that it has engaged Ascenta Finance Corp. to ...

LAUSANNE, Switzerland & MALVERN, Pa.--(BUSINESS WIRE)-- Debiopharm Group™ (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly ...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Ascenta Capital (“Ascenta”), a venture firm investing in multi-medicine development-stage biotechnology companies, today announced the $325 million close of its ...

Bosch hopes to make a machine that's so quiet, you'll barely be able to tell it's running. Its midrange Ascenta series will now bring that comfortable quiet to a more affordable price point. And just ...

LONDON (MarketWatch) -- French drugmaker Sanofi-Aventis said Friday that it has signed a global collaboration and licensing agreement with Ascenta Therapeutics. The deal covers a number of compounds ...

Facebook's $2 billion acquisition of virtual headset maker Oculus VR wasn't the most far-out thing that CEO Mark Zuckerberg bought this week. He also bought a tiny U.K. aerospace company, Ascenta, ...

A British engineering firm based on a remote Somerset farm are to help Facebook launch a network of solar-powered drones that will bring the internet to the remotest places on the planet. The US web ...

MALVERN, Pa., Sept. 10 Ascenta Therapeutics announced today that following the approval by the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) Application for AT-406, an ...

Memorial Day weekend marks the unofficial start of summer and the beginning of extra time spent basking in the sun. While a little dose of Vitamin D is a good thing, too much direct sun exposure - ...

Facebook plans to bring Internet to the third-world via drones, satellites, lasers, and more. Today Mark Zuckerberg unveiled Facebook’s Connectivity Lab which will work on the Internet.org project. It ...

Debiopharm Group™ (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Ascenta Therapeutics, Inc. (Ascenta), a ...